What does an increased red blood cell (RBC) count indicate?

What Does an Increased RBC Count Mean?

An increased RBC count indicates either true polycythemia (actual increase in red blood cell mass) or apparent polycythemia (spurious elevation), and requires systematic evaluation to distinguish between a potentially dangerous clonal myeloproliferative disorder like polycythemia vera versus secondary causes such as hypoxia, dehydration, or other benign conditions 1.

Primary Classification Framework

When you encounter an elevated RBC count, hemoglobin, or hematocrit, you must first determine whether this represents:

1. Apparent (Spurious) Polycythemia

• Relative polycythemia: Reduced plasma volume with normal RBC mass
  • Clinically obvious causes: severe dehydration, diarrhea, vomiting, diuretic use, capillary leak syndrome, severe burns 1
  • These do NOT require red cell mass measurements
• Extreme "high-normal" values: Individual values falling outside the 95th percentile but still physiologically normal for that person 1
  • Must consider sex- and race-adjusted normal ranges before pursuing extensive workup

2. True Polycythemia

This represents actual increase in red blood cell mass and divides into:

A. Polycythemia Vera (PV) - The Critical Diagnosis

• A clonal myeloproliferative neoplasm driven by JAK2 mutations 2
• This is the diagnosis you cannot miss - causes thrombotic/hemorrhagic complications and can progress to myeloid leukemia 2
• Associated with both quantitative (increased RBC count/hematocrit increasing blood viscosity) and qualitative RBC abnormalities (altered deformability, aggregation, adhesion protein expression) 3

B. Secondary Polycythemia (SP) - Nonclonal increase in RBC mass

EPO-mediated, Hypoxia-driven causes:

• Chronic lung disease
• Right-to-left cardiopulmonary shunts
• High-altitude habitation
• Carbon monoxide poisoning (smoker's polycythemia - resolves with smoking cessation) 1
• Hypoventilation syndromes including sleep apnea
• Renal artery stenosis
• High oxygen-affinity hemoglobinopathies (congenital, autosomal-dominant)
• 2,3-Diphosphoglycerate mutase deficiency 1

EPO-mediated, Hypoxia-independent causes:

• Malignant tumors: renal cell cancer, hepatocellular carcinoma, cerebellar hemangioblastoma, parathyroid carcinoma
• Benign tumors: uterine leiomyomas, renal cysts, pheochromocytoma, meningioma
• Chuvash polycythemia (congenital abnormal oxygen homeostasis) 1

EPOR-mediated causes:

• Activating mutations of the EPO receptor
• Some autosomal-dominant congenital polycythemia cases 1

Drug-associated:

• EPO doping
• Androgen preparations 1

Unknown mechanisms:

• Most autosomal-dominant congenital polycythemia
• Post-renal transplant erythrocytosis 1

Diagnostic Approach Algorithm

Step 1: Rule out apparent polycythemia

• Assess for dehydration, diuretic use, or other volume depletion causes
• Verify values against sex- and race-adjusted normal ranges
• Consider if values represent extreme normal variation

Step 2: If true polycythemia suspected, prioritize excluding PV

• Use the TRAKJAK score to predict JAK2 mutation positivity 2
• Test for JAK2 mutations (also consider primary myelofibrosis and essential thrombocythemia)
• This reduces unnecessary downstream testing and costs 2

Step 3: If JAK2 negative, pursue secondary causes

• Measure serum EPO levels (usually elevated in hypoxia-driven SP, low in EPOR mutations)
• Assess oxygen saturation
• Evaluate for hypoxic conditions: pulmonary function tests, sleep study, imaging for shunts
• Screen for tumors if clinically indicated
• Consider hemoglobin oxygen affinity testing if family history suggests congenital cause

Critical Pitfalls to Avoid

• Do not perform red cell mass measurements for clinically obvious volume depletion 1
• Do not dismiss elevated RBC with high hemoglobin as beta-thalassemia trait - this pattern suggests alternative diagnoses like hereditary hemochromatosis, regardless of MCV 4
• Do not overlook that iron deficiency or bleeding can mask PV by lowering RBC mass into the normal range despite underlying disease 1
• Do not assume stress polycythemia or Gaisböck syndrome - these concepts have little foundation and were not identified in systematic Mayo Clinic measurements 1

Clinical Significance

The distinction matters profoundly for morbidity and mortality. PV patients face thrombotic complications from both increased blood viscosity and intrinsic RBC defects including altered deformability, increased adhesion molecule expression, and phosphatidylserine exposure 3. Additionally, PV carries risk of hemorrhage (acquired von Willebrand disease occurs in over one-third of patients) and leukemic transformation 1.